Charles C. Wykoff, MD, PhD
Show Description +
Charles C. Wykoff, MD, PhD, shares positive 24-month safety, efficacy, and functional outcomes from the DERBY and OAKS trials of pegcetacoplan for geographic atrophy.
Posted: 10/10/2022
Charles C. Wykoff, MD, PhD
Charles C. Wykoff, MD, PhD, shares positive 24-month safety, efficacy, and functional outcomes from the DERBY and OAKS trials of pegcetacoplan for geographic atrophy.
Posted: 10/10/2022
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AAO: 2022.
Please log in to leave a comment.